Newormics selected for the NIH I-Corps

Newormics was selected for the NIH I-Corps April-June 2019 cohort. Over the course of the I-Corps program, the team had conversations with over 100 stakeholders in the field. This helped the company gather vital market research to understand the needs and pain points of potential customers, and improve Newormics product lines 

The program finale was held in Washington, DC where Newormics presented for the rest of the I-Corps cohort.

Newormics CEO Adela Ben-Yakar presenting the final presentation in the i-Corps finale in DC alongside co-founder Evan Hegarty

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.